TNFSF10 and B-cell chronic lymphocytic leukemia: We examined a panel of HDACi for their ability to upregulate TRAIL-R1 and -R2 on B-CLL cells from cancer patients, and to sensitize those cells to TRAIL-mediated apoptosis.